IL291351A - Compositions for the treatment of solid tumors - Google Patents

Compositions for the treatment of solid tumors

Info

Publication number
IL291351A
IL291351A IL291351A IL29135122A IL291351A IL 291351 A IL291351 A IL 291351A IL 291351 A IL291351 A IL 291351A IL 29135122 A IL29135122 A IL 29135122A IL 291351 A IL291351 A IL 291351A
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical preparations
solid tumors
tumors
preparations
Prior art date
Application number
IL291351A
Other languages
English (en)
Hebrew (he)
Original Assignee
Raziel Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raziel Therapeutics Ltd filed Critical Raziel Therapeutics Ltd
Publication of IL291351A publication Critical patent/IL291351A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL291351A 2019-09-15 2022-03-14 Compositions for the treatment of solid tumors IL291351A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962900557P 2019-09-15 2019-09-15
PCT/IB2020/000745 WO2021048626A1 (en) 2019-09-15 2020-09-14 Compositions for the treatment of solid tumors

Publications (1)

Publication Number Publication Date
IL291351A true IL291351A (en) 2022-05-01

Family

ID=74866186

Family Applications (1)

Application Number Title Priority Date Filing Date
IL291351A IL291351A (en) 2019-09-15 2022-03-14 Compositions for the treatment of solid tumors

Country Status (7)

Country Link
US (1) US20220323411A1 (https=)
EP (1) EP4031130A4 (https=)
JP (1) JP7822308B2 (https=)
CN (1) CN115066241A (https=)
AU (1) AU2020347539A1 (https=)
IL (1) IL291351A (https=)
WO (1) WO2021048626A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3307323B1 (en) 2015-06-15 2022-07-13 Raziel Therapeutics Ltd. Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof
EP4334286A4 (en) * 2021-05-06 2025-03-19 Raziel Therapeutics Ltd. CRYSTALLINE CARBAZOLE DERIVATIVE
CN120693158A (zh) * 2022-11-07 2025-09-23 拉结尔治疗有限公司 结晶咔唑衍生物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0311406D0 (en) * 2003-05-17 2003-06-25 Queen Mary & Westfield College Substituted phosphonate fluorescent sensors,and use thereof
UA107652C2 (en) 2008-10-06 2015-02-10 Incuron Llc Carbazole compounds and therapeutic uses of the compounds
KR101986272B1 (ko) * 2011-11-15 2019-06-05 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. 삼환식 화합물, 이를 포함하는 조성물 및 그의 용도
EP3307323B1 (en) * 2015-06-15 2022-07-13 Raziel Therapeutics Ltd. Carbazole derivatives for the treatment of fibrotic diseases and related symptoms, and conditions thereof
US20230089484A1 (en) 2020-01-28 2023-03-23 Raziel Therapeutics Ltd. Compositions for the treatment of angiolipoma

Also Published As

Publication number Publication date
EP4031130A1 (en) 2022-07-27
AU2020347539A1 (en) 2022-03-31
CN115066241A (zh) 2022-09-16
JP2023503769A (ja) 2023-02-01
EP4031130A4 (en) 2023-10-11
WO2021048626A1 (en) 2021-03-18
US20220323411A1 (en) 2022-10-13
JP7822308B2 (ja) 2026-03-02

Similar Documents

Publication Publication Date Title
CL2020002043A1 (es) Métodos y composiciones para la entrega de proteínas terapeuticas.
IL269150A (en) Compositions and methods for treating cancer
IL268814A (en) Compositions and methods for treatment of cancer
PT3717471T (pt) Novos compostos e composições farmacêuticas dos mesmos para o tratamento de doenças
SG11202104923YA (en) Pharmaceutical combination for treatment of cancer
PL3600309T3 (pl) Skojarzenia terapeutyczne do leczenia chorób wątroby
DK3616720T3 (da) Farmaceutisk sammensætning til cancerbehandling
MX2023002507A (es) Inhibidores de cd73.
IL284414A (en) Methods and compositions for the treatment of fabry disease
MX2022005256A (es) Inhibidores de cd73.
IL272601A (en) Pharmaceutical compositions for the treatment of ophthalmic conditions
IL269157A (en) Compositions and methods for treating cancer
HUE059584T2 (hu) Gyógyszerészeti készítmény vérszegénység kezelésére
EP3915583A4 (en) COMBINED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TUMORS
IL281244A (en) Combination therapy for the treatment of liver disease
HUE060496T2 (hu) Terápiás vegyületek és készítmények szociális zavarok és szerhasználati zavarok kezelésére
KR102735988B9 (ko) 치료 항체 제제
IL291351A (en) Compositions for the treatment of solid tumors
IL280664A (en) 2-arylbenzimidazoles as ppargc1a activators for treating neurodegenerative diseases
HUE053648T2 (hu) Gyógyászati kombinációk rák kezelésére
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
SMT202300325T1 (it) Composizioni farmaceutiche antitumorali per terapia combinata
IL264603A (en) Reelin compositions for treatment of neurological disorders
IL275525A (en) A pharmaceutical preparation for the treatment of cancer
IL289251A (en) Methods and compositions for treatment of pancreatic cancer